Publication: Declining responsiveness of plasmodium falciparum infections to Artemisinin-Based combination treatments on the Kenyan coast
Issued Date
2011-11-10
Resource Type
ISSN
19326203
Other identifier(s)
2-s2.0-80755159531
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
PLoS ONE. Vol.6, No.11 (2011)
Suggested Citation
Steffen Borrmann, Philip Sasi, Leah Mwai, Mahfudh Bashraheil, Ahmed Abdallah, Steven Muriithi, Henrike Frühauf, Barbara Schaub, Johannes Pfeil, Judy Peshu, Warunee Hanpithakpong, Anja Rippert, Elizabeth Juma, Benjamin Tsofa, Moses Mosobo, Brett Lowe, Faith Osier, Greg Fegan, Niklas Lindegårdh, Alexis Nzila, Norbert Peshu, Margaret Mackinnon, Kevin Marsh Declining responsiveness of plasmodium falciparum infections to Artemisinin-Based combination treatments on the Kenyan coast. PLoS ONE. Vol.6, No.11 (2011). doi:10.1371/journal.pone.0026005 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/11239
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Declining responsiveness of plasmodium falciparum infections to Artemisinin-Based combination treatments on the Kenyan coast
Author(s)
Steffen Borrmann
Philip Sasi
Leah Mwai
Mahfudh Bashraheil
Ahmed Abdallah
Steven Muriithi
Henrike Frühauf
Barbara Schaub
Johannes Pfeil
Judy Peshu
Warunee Hanpithakpong
Anja Rippert
Elizabeth Juma
Benjamin Tsofa
Moses Mosobo
Brett Lowe
Faith Osier
Greg Fegan
Niklas Lindegårdh
Alexis Nzila
Norbert Peshu
Margaret Mackinnon
Kevin Marsh
Philip Sasi
Leah Mwai
Mahfudh Bashraheil
Ahmed Abdallah
Steven Muriithi
Henrike Frühauf
Barbara Schaub
Johannes Pfeil
Judy Peshu
Warunee Hanpithakpong
Anja Rippert
Elizabeth Juma
Benjamin Tsofa
Moses Mosobo
Brett Lowe
Faith Osier
Greg Fegan
Niklas Lindegårdh
Alexis Nzila
Norbert Peshu
Margaret Mackinnon
Kevin Marsh
Abstract
Background: The emergence of artemisinin-resistant P. falciparum malaria in South-East Asia highlights the need for continued global surveillance of the efficacy of artemisinin-based combination therapies. Methods: On the Kenyan coast we studied the treatment responses in 474 children 6-59 months old with uncomplicated P. falciparum malaria in a randomized controlled trial of dihydroartemisinin-piperaquine vs. artemether-lumefantrine from 2005 to 2008. (ISRCTN88705995) Results: The proportion of patients with residual parasitemia on day 1 rose from 55% in 2005-2006 to 87% in 2007-2008 (odds ratio, 5.4, 95%CI, 2.7-11.1; P < 0.001) and from 81% to 95% (OR, 4.1, 95%CI, 1.7-9.9; P = 0.002) in the DHA-PPQ and AM-LM groups, respectively. In parallel, Kaplan-Meier estimated risks of apparent recrudescent infection by day 84 increased from 7% to 14% (P = 0.1) and from 6% to 15% (P = 0.05) with DHA-PPQ and AM-LM, respectively. Coinciding with decreasing transmission in the study area, clinical tolerance to parasitemia (defined as absence of fever) declined between 2005-2006 and 2007-2008 (OR body temperature > 37.5°C, 2.8, 1.9-4.1; P < 0.001). Neither in vitro sensitivity of parasites to DHA nor levels of antibodies against parasite extract accounted for parasite clearance rates or changes thereof. Conclusions: The significant, albeit small, decline through time of parasitological response rates to treatment with ACTs may be due to the emergence of parasites with reduced drug sensitivity, to the coincident reduction in population-level clinical immunity, or both. Maintaining the efficacy of artemisinin-based therapy in Africa would benefit from a better understanding of the mechanisms underlying reduced parasite clearance rates. Trial Registration: Controlled-Trials.com ISRCTN88705995. © 2011 Borrmann et al.